ArticleJournal for immunotherapy of cancer2021

In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.

Takaaki Oba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.